受强制性开放获取政策约束的文章 - Roger A Barker了解详情
整体NIHRMRCWellcomeParkinson's UKNIHEuropean CommissionSwedish Research CouncilUK Research & InnovationCIHRFRQSMichael J Fox FoundationEPSRCBBSRCNHMRCParkinson's Foundation, USAAlzheimers's UKCancer Research UKFWOKnut and Alice Wallenberg FoundationMotor Neurone Disease Association, UKZonMwBHFRCNGovernment of SpainGovernment of ItalyASAPDoDINSERMBMBFCZIDFGNWONSFCVersus Arthritis, UKACLNSERCEMBLAcademy of Medical Sciences, UKESRCNSFSNSFGatesVolkswagen FoundationDFFWellcome Trust/DBT India AllianceRannisTelethonA*StarCSOStroke Association, UKKWFNMRCHFSPVAHHMIGenome CanadaHelmholtzSFIBlood Cancer UKDMTNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKNRFFondazione CariploANRInnovation Fund DenmarkBrain Research, UKHuntington Society of CansdaRoyal Society UKHealth and Care Research Wales
无法在其他位置公开访问的文章:30 篇
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
GW Duncan, TK Khoo, AJ Yarnall, JT O'Brien, SY Coleman, DJ Brooks, ...
Movement disorders 29 (2), 195-202, 2014
强制性开放获取政策: UK Medical Research Council, Parkinson's UK
Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease
A Goris, CH Williams‐Gray, GR Clark, T Foltynie, SJG Lewis, J Brown, ...
Annals of neurology 62 (2), 145-153, 2007
强制性开放获取政策: Research Foundation (Flanders)
The clinical heterogeneity of Parkinson's disease and its therapeutic implications
JC Greenland, CH Williams‐Gray, RA Barker
European Journal of Neuroscience 49 (3), 328-338, 2019
强制性开放获取政策: UK Medical Research Council, National Institute for Health Research, UK …
Systematic Review and UK‐Based Study of PARK2 (parkin), PINK1, PARK7 (DJ‐1) and LRRK2 in early‐onset Parkinson's disease
LL Kilarski, JP Pearson, V Newsway, E Majounie, MDW Knipe, ...
Movement Disorders 27 (12), 1522-1529, 2012
强制性开放获取政策: Parkinson's UK
Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
JG de Yebenes, B Landwehrmeyer, F Squitieri, R Reilmann, A Rosser, ...
The Lancet Neurology 10 (12), 1049-1057, 2011
强制性开放获取政策: Government of Spain
Gray and white matter imaging: A biomarker for cognitive impairment in early P arkinson's disease?
GW Duncan, MJ Firbank, AJ Yarnall, TK Khoo, DJ Brooks, RA Barker, ...
Movement Disorders 31 (1), 103-110, 2016
强制性开放获取政策: National Institute for Health Research, UK, Parkinson's UK
Time course of dopamine neuron loss and glial response in the 6‐OHDA striatal mouse model of P arkinson's disease
SRW Stott, RA Barker
European Journal of Neuroscience 39 (6), 1042-1056, 2014
强制性开放获取政策: Parkinson's UK
Huntington’s disease: Diagnosis and management
TB Stoker, SL Mason, JC Greenland, ST Holden, H Santini, RA Barker
Practical neurology 22 (1), 32-41, 2022
强制性开放获取政策: UK Medical Research Council, National Institute for Health Research, UK
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
R Reilmann, A McGarry, ID Grachev, JM Savola, B Borowsky, E Eyal, ...
The Lancet Neurology 18 (2), 165-176, 2019
强制性开放获取政策: US National Institutes of Health, German Research Foundation, UK Medical …
Determinants of delayed diagnosis in Parkinson’s disease
DP Breen, JR Evans, K Farrell, C Brayne, RA Barker
Journal of Neurology 260, 1978-1981, 2013
强制性开放获取政策: Parkinson's UK
Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome
SE Winder‐Rhodes, P Garcia‐Reitböck, M Ban, JR Evans, TS Jacques, ...
Movement disorders 27 (2), 312-315, 2012
强制性开放获取政策: Parkinson's UK
Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain
RA Barker, I de Beaufort
Progress in neurobiology 110, 63-73, 2013
强制性开放获取政策: UK Medical Research Council, Parkinson's UK, Wellcome Trust
Addenbrooke's Cognitive Examination‐Revised for mild cognitive impairment in Parkinson's disease
P McColgan, JR Evans, DP Breen, SL Mason, RA Barker, ...
Movement Disorders 27 (9), 1173-1177, 2012
强制性开放获取政策: Parkinson's UK
Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations
WR Galpern, J Corrigan-Curay, AE Lang, J Kahn, D Tagle, RA Barker, ...
The Lancet Neurology 11 (7), 643-650, 2012
强制性开放获取政策: US National Institutes of Health, Canadian Institutes of Health Research
Excessive daytime sleepiness and its risk factors in incident Parkinson's disease
DP Breen, CH Williams-Gray, SL Mason, T Foltynie, RA Barker
Journal of Neurology, Neurosurgery & Psychiatry 84 (2), 233-234, 2013
强制性开放获取政策: Parkinson's UK
Recent advances in the development of stem‐cell‐derived dopaminergic neuronal transplant therapies for Parkinson's disease
PA Barbuti, RA Barker, P Brundin, S Przedborski, SM Papa, LV Kalia, ...
Movement Disorders 36 (8), 1772-1780, 2021
强制性开放获取政策: US National Institutes of Health, Canadian Institutes of Health Research …
Human fetal neural precursor cells can up-regulate MHC class I and class II expression and elicit CD4 and CD8 T cell proliferation
RL Goya, R Busch, R Mathur, AJ Coles, RA Barker
Neurobiology of Disease 41 (2), 407-414, 2011
强制性开放获取政策: Versus Arthritis, UK
Stem cells and the treatment of Parkinson's disease
F Ali, SRW Stott, RA Barker
Experimental neurology 260, 3-11, 2014
强制性开放获取政策: National Institute for Health Research, UK, Wellcome Trust
Predictors of Parkinson's disease dementia: towards targeted therapies for a heterogeneous disease
SF Moore, RA Barker
Parkinsonism & related disorders 20, S104-S107, 2014
强制性开放获取政策: Parkinson's UK, Wellcome Trust
Investigation of TGFB2 as a candidate gene in multiple sclerosis and Parkinson’s disease
A Goris, CH Williams-Gray, T Foltynie, J Brown, M Maranian, A Walton, ...
Journal of neurology 254, 846-848, 2007
强制性开放获取政策: Research Foundation (Flanders)
出版信息和资助信息由计算机程序自动确定